Transcranial Magnetic Stimulation TMS Machine for Alzheimer’s and Depression

Magnetic Field Strength	the weak stage is 6mT～10mT, the strong stage is 11mT～19mT;
Vibration Intensity	1~10 range is adjustable
Vibration Mode	12 adjustable modes
Treatment time	within the range of 0-30 minutes, ±1 minute each time
Function	vibration massage
Prescription	1–7: variable frequency; 8–16: fixed frequency
Types of Magnetic Therapy Caps	adults / children (Default: Adult)
Environmental temperature range	5℃～40℃
Rated input power	150VA
Power	AC 220V±22V

Who Can Benefit From This Machine?

Product Features and Advantages

Painless and Non Invasive
Utilizing a purely physical form of transcranial magnetic stimulation therapy, this approach constitutes a non-invasive mode of physical treatment. The entire treatment process requires no injections, oral medications, punctures, or surgical incisions, thereby causing no traumatic stimulation to the scalp, skull, or brain tissue. The procedure is gentle and soothing; patients experience a sense of comfort without any pain, and—being free of side effects and traumatic risks—it can be used with complete peace of mind by people of all age groups.

Easy to Use
The device is simple and intuitive to operate, featuring a large, high-definition touchscreen panel with clearly labeled function buttons. No specialized technical expertise is required; with just a few simple steps, users can select modes and adjust parameters. Its low barrier to entry ensures that even the elderly and complete beginners can easily operate the device independently.

Full Touchscreen Operation Panel
Equipped with a full-touch control panel. The large touch screen displays parameters including treatment time, prescriptions, vibration mode and intensity, as well as magnetic field intensity clearly, enabling convenient and efficient operation.

Adjustable Parameters
Multiple parameters are adjustable, including treatment time, magnetic field strength and vibration level to customize personalized therapy.

Magnetic Therapy Cap
The all-round three-dimensional mesh magnetic therapy cap fully covers the head. Magnetic fields with specific intensity and frequency generated by magnetic stimulation coils penetrate the scalp and skull, acting precisely on specific cerebral cortex areas and head acupoints.Standard configuration comes with adult magnetic therapy cap. Please leave a note if you need the child version.

Suitable for All Ages
The device suits people of all ages with customized modes for different physical conditions and dedicated therapy caps. It helps seniors maintain brain health and relieve illnesses, comforts children with gentle intensity, and supports daily brain care for adults. Featuring strong compatibility and wide application range, it is safe for the whole family to use.

Three Key Therapeutic Mechanisms

How to Use

Treatment Course Recommendations

Application Scenarios

Functions and Improvements

Alzheimers

1. Mechanism of Action
Alzheimer’s disease is characterized primarily by the degeneration of neurons in cognition-related brain regions (specifically the hippocampus and prefrontal cortex), the weakening of synaptic connections, and the manifestation of behavioral and psychological symptoms (BPSD)—such as hallucinations and delusions. The rTMS technology employed by this device enhances cortical excitability through a mechanism known as “Long-Term Potentiation” (LTP). After penetrating the skull, the magnetic field targets key areas—including the hippocampus (the center for memory formation) and the prefrontal cortex—to facilitate autonomous signal transmission within damaged neurons and strengthen synaptic connections. Simultaneously, it suppresses abnormal brainwave activity (such as the disordered neuronal firing that triggers hallucinations), thereby alleviating the cognitive and behavioral impairments associated with neurodegeneration.
2. Post-Treatment Improvements
Cognitive Function: Short-term memory improves, enabling patients to recall family members’ names and their home address, and to recollect minor recent events (e.g., “I ate eggs for breakfast this morning”). Furthermore, the frequency of forgetting significant events from long-term memory (e.g., children’s birthdays) is reduced.
Behavioral Abnormalities: Symptoms of BPSD—such as hallucinations (e.g., “seeing people who aren’t there”) and delusions (e.g., “suspecting family members of theft”)—gradually subside. Patients cease engaging in disruptive behavior or wandering aimlessly at night, and their emotional state becomes more stable.
Self-Care Capabilities: Patients regain the ability to independently perform simple daily activities, such as dressing themselves, eating, and organizing personal belongings; they may even be able to assist family members with light household chores (e.g., wiping tables or folding laundry).

Depression

1. Mechanism of Action
The core pathology of depression is associated with functional abnormalities in the brain regions responsible for emotional regulation (such as the dorsolateral prefrontal cortex, or DLPFC), as well as a deficiency in the secretion of “happiness neurotransmitters”—such as serotonin (5-HT) and norepinephrine (NE). Utilizing rTMS technology, this device precisely targets emotion-related brain regions—including the prefrontal cortex and the limbic system—with magnetic fields of specific frequencies. On one hand, it corrects states of excessive inhibition or excitation within these abnormal brain regions, thereby restoring coordinated activity between different areas of the brain. On the other hand, it promotes the release of neurotransmitters—such as serotonin and dopamine—to compensate for deficient levels, thereby enhancing emotional regulation capabilities at a physiological level.
2. Post-Treatment Improvements
Emotional State: Persistent low mood and feelings of pessimism or hopelessness are significantly alleviated; interest in daily activities (such as hobbies and social engagements) is gradually restored; and feelings of “meaninglessness” and “self-blame” are reduced.
Somatic Symptoms: Accompanying physical symptoms—such as insomnia, early-morning awakening, and changes in appetite (either reduction or increase)—are improved, and body weight gradually returns to a normal range.
Social Functioning: Individuals are able to actively participate in family interactions, work, or academic studies; they no longer avoid social situations; they are able to complete simple daily tasks (such as shopping or commuting); and their overall energy levels are enhanced.

Insomnia

1. Mechanism of Action
At the core of insomnia lies a disturbance in the brainwaves within the sleep centers (specifically the prefrontal cortex and hypothalamus), or an insufficient secretion of sleep-regulating neurotransmitters such as serotonin and melatonin. This device improves sleep through a “dual-action regulation” mechanism: on one hand, rTMS applies a gentle magnetic field to the prefrontal cortex, modulating chaotic brainwaves (such as hyperactive beta waves) into normal sleep rhythms (such as the delta waves characteristic of slow-wave sleep and the theta waves associated with light sleep); on the other hand, the accompanying vibration massage function relaxes head muscles and alleviates anxiety, thereby reducing “pre-sleep rumination” and creating both the physiological and psychological conditions necessary for falling asleep.
2. Post-Treatment Improvements
Sleep Onset Efficiency: The time required to fall asleep is reduced from “over 30 minutes” to “within 15–20 minutes,” eliminating the need to “count sheep until dawn.”
Sleep Quality: The frequency of nighttime awakenings decreases from “≥2 times” to “0–1 time”; symptoms of early-morning awakening (e.g., waking up at 3:00 AM and being unable to fall back asleep) are alleviated, allowing for 6–8 hours of continuous sleep.
Daytime Functioning: Users no longer experience frequent daytime drowsiness or mental fog; instead, they feel energetic and capable of performing work or academic tasks normally, while also experiencing a reduction in the irritability and agitation often associated with sleep deprivation.

Parkinsons

1. Mechanism of Action
At the core of Parkinson’s disease lies the impairment of dopaminergic neurons within the brain’s basal ganglia, leading to the abnormal activation of neuroinflammation in the motor cortex and the disruption of motor signal transmission. The rTMS therapy delivered by this device operates through a dual mechanism: on one hand, it modulates peripheral regulatory T cells (Tregs) to suppress neuroinflammatory responses and mitigate further damage to dopaminergic neurons; on the other hand, it targets motor-related brain regions—such as the motor cortex and basal ganglia—to enhance the excitability of motor neural pathways and restore impaired motor signal transmission.
2. Post-Treatment Improvements
Motor Symptoms: Limb tremors (e.g., the “pill-rolling tremor” of the hands) are significantly alleviated, and the frequency of resting tremors is reduced; limb rigidity (e.g., “stiff joints”) is relieved, enabling patients to voluntarily bend their arms and lift their legs; bradykinesia (e.g., “shuffling gait” or “slow turning”) improves, resulting in a steadier gait and increased stride length.
Self-Care Abilities: Patients are able to independently perform fine motor tasks—such as using chopsticks to eat, buttoning clothes, and tying shoelaces—without requiring assistance from family members.
Quality of Life: The reluctance to venture outdoors—often stemming from motor impairments—is diminished; patients are able to take short walks and go shopping, leading to increased participation in social activities.

Stroke Rehabilitation

1. Mechanism of Action
Following a stroke (such as cerebral infarction or cerebral hemorrhage), regions of the brain—including the motor cortex and language centers (Broca’s and Wernicke’s areas)—sustain damage due to ischemia or hemorrhage, resulting in symptoms such as motor impairments and aphasia. The rTMS (repetitive Transcranial Magnetic Stimulation) technology employed by this device exerts its therapeutic effects through a mechanism known as “neural remodeling”: magnetic fields penetrate the skull to act directly upon the damaged brain regions, thereby promoting autonomous signal transmission within brain cells (effectively resuscitating compromised neurons). Simultaneously, the treatment improves cerebrovascular elasticity and dilates microcirculation channels (facilitating the establishment of collateral circulation), ensuring an adequate supply of oxygenated blood to the damaged areas and accelerating the restoration of neurological function.
2. Post-Treatment Improvements
Motor Function: Muscle strength is restored in the limbs on the paralyzed side following the stroke (e.g., the right arm and leg); patients regain the ability to voluntarily lift their arms, stand, and walk, and may even be able to ascend and descend stairs while using a wall for support. Fine motor skills (such as grasping a cup or writing) also show gradual recovery.
Language Function (for patients with aphasia): Patients suffering from expressive aphasia become capable of articulating complete short sentences (e.g., “I want some water”) and no longer speak in a halting or disjointed manner. Patients with receptive aphasia gain the ability to comprehend instructions given by family members (e.g., “Hand me the towel”), and instances of providing irrelevant or nonsensical responses are significantly reduced.
Self-Care Capabilities: Patients become capable of independently performing daily activities—such as washing, dressing, and eating—thereby reducing their reliance on family members. Furthermore, some patients may be able to return to light-duty employment (such as office-based clerical work).

Package List